{"title":"乳腺健康导航:乳腺非典型导管增生管理和监测的综合方法","authors":"Nadia Islam, Suneela Vegunta","doi":"10.37349/emed.2024.00205","DOIUrl":null,"url":null,"abstract":"Atypical ductal hyperplasia (ADH) is a benign lesion of the breast that is associated with an increased risk of invasive breast cancer. This review explores the pathophysiology, risk factors for progression to breast cancer, and lifetime management for patients diagnosed with ADH on core needle biopsy (CNB). The management plan for patients diagnosed with ADH includes regular clinical surveillance, diagnostic mammography, along with risk-reduction strategies such as lifestyle modifications or the use of adjuvant endocrine therapies. This review aims to delve into the complexities of ADH from diagnosis to management to aid clinicians in finding the best way to approach this high-risk breast lesion.","PeriodicalId":507580,"journal":{"name":"Exploration of Medicine","volume":"70 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Navigating breast health: a comprehensive approach to atypical ductal hyperplasia of the breast management and surveillance\",\"authors\":\"Nadia Islam, Suneela Vegunta\",\"doi\":\"10.37349/emed.2024.00205\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Atypical ductal hyperplasia (ADH) is a benign lesion of the breast that is associated with an increased risk of invasive breast cancer. This review explores the pathophysiology, risk factors for progression to breast cancer, and lifetime management for patients diagnosed with ADH on core needle biopsy (CNB). The management plan for patients diagnosed with ADH includes regular clinical surveillance, diagnostic mammography, along with risk-reduction strategies such as lifestyle modifications or the use of adjuvant endocrine therapies. This review aims to delve into the complexities of ADH from diagnosis to management to aid clinicians in finding the best way to approach this high-risk breast lesion.\",\"PeriodicalId\":507580,\"journal\":{\"name\":\"Exploration of Medicine\",\"volume\":\"70 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Exploration of Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37349/emed.2024.00205\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploration of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37349/emed.2024.00205","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
非典型导管增生(ADH)是一种乳腺良性病变,与浸润性乳腺癌风险增加有关。这篇综述探讨了病理生理学、发展为乳腺癌的风险因素以及核心针活检(CNB)确诊为 ADH 患者的终生管理。对确诊为 ADH 患者的管理计划包括定期临床监测、诊断性乳房 X 线照相术以及降低风险的策略,如改变生活方式或使用辅助内分泌疗法。本综述旨在深入探讨ADH从诊断到治疗的复杂性,帮助临床医生找到治疗这种高危乳腺病变的最佳方法。
Navigating breast health: a comprehensive approach to atypical ductal hyperplasia of the breast management and surveillance
Atypical ductal hyperplasia (ADH) is a benign lesion of the breast that is associated with an increased risk of invasive breast cancer. This review explores the pathophysiology, risk factors for progression to breast cancer, and lifetime management for patients diagnosed with ADH on core needle biopsy (CNB). The management plan for patients diagnosed with ADH includes regular clinical surveillance, diagnostic mammography, along with risk-reduction strategies such as lifestyle modifications or the use of adjuvant endocrine therapies. This review aims to delve into the complexities of ADH from diagnosis to management to aid clinicians in finding the best way to approach this high-risk breast lesion.